Targeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies

The introduction of a wide range of immunotherapies in clinical practice has revolutionized the treatment of cancer in the last decade. The majority of these therapeutic modalities are centered on reinvigorating a tumor-reactive cytotoxic T-cell response. While impressive clinical successes are obta...

Descripción completa

Detalles Bibliográficos
Autores principales: Harryvan, Tom J., Verdegaal, Els M. E., Hardwick, James C. H., Hawinkels, Lukas J. A. C., van der Burg, Sjoerd H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912330/
https://www.ncbi.nlm.nih.gov/pubmed/31731701
http://dx.doi.org/10.3390/jcm8111989

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6912330/
https://www.ncbi.nlm.nih.gov/pubmed/31731701
http://dx.doi.org/10.3390/jcm8111989

Ejemplares similares